• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

队列资料简介:西开普孕期暴露登记处(WCPER)。

Cohort profile: the Western Cape Pregnancy Exposure Registry (WCPER).

机构信息

Centre for Infectious Disease Epidemiology & Research, University of Cape Town Faculty of Health Sciences, Cape Town, South Africa

Centre for Infectious Disease Epidemiology & Research, University of Cape Town Faculty of Health Sciences, Cape Town, South Africa.

出版信息

BMJ Open. 2022 Jun 29;12(6):e060205. doi: 10.1136/bmjopen-2021-060205.

DOI:10.1136/bmjopen-2021-060205
PMID:35768089
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9244673/
Abstract

PURPOSE

The Western Cape Pregnancy Exposure Registry (PER) was established at two public sector healthcare sentinel sites in the Western Cape province, South Africa, to provide ongoing surveillance of drug exposures in pregnancy and associations with pregnancy outcomes.

PARTICIPANTS

Established in 2016, all women attending their first antenatal visit at primary care obstetric facilities were enrolled and followed to pregnancy outcome regardless of the site (ie, primary, secondary, tertiary facility). Routine operational obstetric and medical data are digitised from the clinical stationery at the healthcare facilities. Data collection has been integrated into existing services and information platforms and supports routine operations. The PER is situated within the Provincial Health Data Centre, an information exchange that harmonises and consolidates all health-related electronic data in the province. Data are contributed via linkage across a unique identifier. This relationship limits the missing data in the PER, allows validation and avoids misclassification in the population-level data set.

FINDINGS TO DATE

Approximately 5000 and 3500 pregnant women enter the data set annually at the urban and rural sites, respectively. As of August 2021, >30 000 pregnancies have been recorded and outcomes have been determined for 93%. Analysis of key obstetric and neonatal health indicators derived from the PER are consistent with the aggregate data in the District Health Information System.

FUTURE PLANS

This represents significant infrastructure, able to address clinical and epidemiological concerns in a low/middle-income setting.

摘要

目的

西开普妊娠暴露登记处(PER)在南非西开普省的两个公立医疗机构哨点设立,以对妊娠期间的药物暴露及其与妊娠结局的相关性进行持续监测。

参与者

该登记处于 2016 年设立,所有在初级保健产科设施首次产前就诊的妇女均被纳入并随访至妊娠结局,无论其就诊的是初级、中级还是三级医疗机构。常规产科和医疗数据从医疗机构的临床记录中数字化。数据收集已整合到现有服务和信息平台中,并支持常规运作。PER 位于省级卫生数据中心内,该中心是一个信息交换中心,协调和整合了省内所有与健康相关的电子数据。数据通过唯一标识符进行链接贡献。这种关系限制了 PER 中的缺失数据,允许在人群水平数据集进行验证和避免分类错误。

迄今为止的发现

每年约有 5000 名和 3500 名孕妇分别进入城市和农村地区的数据组。截至 2021 年 8 月,已记录了超过 30000 例妊娠,其中 93%的妊娠结局已经确定。从 PER 中得出的关键产科和新生儿健康指标的分析结果与地区卫生信息系统的汇总数据一致。

未来计划

这代表着一个重要的基础设施,能够解决中低收入环境中的临床和流行病学问题。

相似文献

1
Cohort profile: the Western Cape Pregnancy Exposure Registry (WCPER).队列资料简介:西开普孕期暴露登记处(WCPER)。
BMJ Open. 2022 Jun 29;12(6):e060205. doi: 10.1136/bmjopen-2021-060205.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Assessing the value of Western Cape Provincial Government health administrative data and electronic pharmacy records in ascertaining medicine use during pregnancy.评估西开普省政府卫生行政数据和电子药房记录在确定孕期用药情况方面的价值。
S Afr Med J. 2018 Apr 25;108(5):439-443. doi: 10.7196/SAMJ.2018.v108i5.12879.
4
Exploring the validity of routine individuated service data for antenatal HIV surveillance in the Western Cape.探索西开普省产前艾滋病毒监测常规个性化服务数据的有效性。
BMC Infect Dis. 2025 Mar 4;25(1):309. doi: 10.1186/s12879-025-10639-6.
5
Population-based prevalence of congenital defects in a routine sentinel site-based surveillance system in the Western Cape, South Africa.南非西开普省常规哨点监测系统中先天性缺陷的基于人群的患病率。
Birth Defects Res. 2024 Aug;116(8):e2388. doi: 10.1002/bdr2.2388.
6
Can routine antenatal data be used to assess HIV antiretroviral therapy coverage among pregnant women? Evaluating the validity of different data sources in the Western Cape, South Africa.能否利用常规产前数据评估南非西开普省孕妇的抗逆转录病毒治疗覆盖率?评估不同数据源的有效性。
PLoS One. 2024 Apr 18;19(4):e0291844. doi: 10.1371/journal.pone.0291844. eCollection 2024.
7
A longitudinal analysis of the completeness of maternal HIV testing, including repeat testing in Cape Town, South Africa.南非开普敦的纵向分析孕产妇 HIV 检测的完整性,包括重复检测。
J Int AIDS Soc. 2020 Jan;23(1):e25441. doi: 10.1002/jia2.25441.
8
Maternal and newborn outcomes in Pakistan compared to other low and middle income countries in the Global Network's Maternal Newborn Health Registry: an active, community-based, pregnancy surveillance mechanism.与全球网络孕产妇和新生儿健康登记处的其他低收入和中等收入国家相比,巴基斯坦的孕产妇和新生儿结局:一种基于社区的主动妊娠监测机制。
Reprod Health. 2015;12 Suppl 2(Suppl 2):S15. doi: 10.1186/1742-4755-12-S2-S15. Epub 2015 Jun 8.
9
Protocol for a drugs exposure pregnancy registry for implementation in resource-limited settings.资源有限环境下实施的药物暴露妊娠登记研究方案。
BMC Pregnancy Childbirth. 2012 Sep 3;12:89. doi: 10.1186/1471-2393-12-89.
10
A mixed reception: perceptions of pregnant adolescents' experiences with health care workers in Cape Town, South Africa.喜忧参半:南非开普敦孕妇青少年对医疗工作者体验的看法。
Reprod Health. 2021 Aug 4;18(1):167. doi: 10.1186/s12978-021-01211-x.

引用本文的文献

1
Screening for retinopathy of prematurity in South Africa: are those developing severe ROP screened on time? Data from a prospective register.南非早产儿视网膜病变的筛查:那些发展为严重早产儿视网膜病变的患儿是否得到了及时筛查?来自前瞻性登记的数据。
BMJ Open Ophthalmol. 2025 Jul 13;10(1):e002239. doi: 10.1136/bmjophth-2025-002239.
2
Cohort profile: measuring adverse pregnancy and newborn congenital outcomes (MANGO) study in Kenya.队列简介:肯尼亚测量不良妊娠和新生儿先天性结局(MANGO)研究
BMJ Open. 2025 Apr 30;15(4):e092430. doi: 10.1136/bmjopen-2024-092430.
3
Antiretroviral Use for HIV Prevention During Pregnancy: The Need to Strengthen Regulatory and Surveillance Systems in Africa.孕期使用抗逆转录病毒药物预防艾滋病毒:非洲加强监管和监测系统的必要性。
Drug Saf. 2025 Mar;48(3):209-216. doi: 10.1007/s40264-024-01494-6. Epub 2025 Jan 26.
4
Population-based prevalence of congenital defects in a routine sentinel site-based surveillance system in the Western Cape, South Africa.南非西开普省常规哨点监测系统中先天性缺陷的基于人群的患病率。
Birth Defects Res. 2024 Aug;116(8):e2388. doi: 10.1002/bdr2.2388.
5
Pharmacovigilance in Pregnancy Studies, Exposures and Outcomes Ascertainment, and Findings from Low- and Middle-Income Countries: A Scoping Review.妊娠研究中的药物警戒、暴露和结局确定,以及来自中低收入国家的发现:范围综述。
Drug Saf. 2024 Oct;47(10):957-990. doi: 10.1007/s40264-024-01445-1. Epub 2024 Jun 21.
6
The cyclical cascade of HIV care: Temporal care engagement trends within a population-wide cohort.HIV 护理的周期性级联:全人群队列中临时护理参与趋势。
PLoS Med. 2024 May 10;21(5):e1004407. doi: 10.1371/journal.pmed.1004407. eCollection 2024 May.
7
Association between tuberculosis and pregnancy outcomes: a retrospective cohort study of women in Cape Town, South Africa.结核病与妊娠结局的关联:南非开普敦妇女的回顾性队列研究。
BMJ Open. 2024 Feb 7;14(2):e081209. doi: 10.1136/bmjopen-2023-081209.
8
Safety surveillance for PrEP in pregnant and breastfeeding women.孕妇和哺乳期妇女中暴露前预防的安全性监测。
Front Reprod Health. 2023 Sep 29;5:1221101. doi: 10.3389/frph.2023.1221101. eCollection 2023.

本文引用的文献

1
Determining antenatal medicine exposures in South African women: a comparison of three methods of ascertainment.确定南非女性的产前医学暴露:三种确定方法的比较。
BMC Pregnancy Childbirth. 2022 Jun 3;22(1):466. doi: 10.1186/s12884-022-04765-1.
2
An imperative to offer pregnant and lactating women access to the COVID-19 vaccination roll-out programme.呼吁为孕妇和哺乳期妇女提供 COVID-19 疫苗接种服务。
S Afr Med J. 2021 Apr 12;111(6):567-569.
3
Use of Primary Care Data in Research and Pharmacovigilance: Eight Scenarios Where Prescription Data are Absent.在研究和药物警戒中使用初级保健数据:八种处方数据缺失的情况。
Drug Saf. 2021 Oct;44(10):1033-1040. doi: 10.1007/s40264-021-01093-9. Epub 2021 Jul 22.
4
Limited surface examination to evaluate potential teratogens in a resource-limited setting.在资源有限的环境中进行有限的表面检查以评估潜在致畸物。
Birth Defects Res. 2021 May 15;113(9):702-707. doi: 10.1002/bdr2.1887. Epub 2021 Mar 28.
5
Maternal and neonatal data collection systems in low- and middle-income countries for maternal vaccines active safety surveillance systems: A scoping review.中低收入国家孕产妇和新生儿数据收集系统在孕产妇疫苗主动安全性监测系统中的应用:系统评价。
BMC Pregnancy Childbirth. 2021 Mar 17;21(1):217. doi: 10.1186/s12884-021-03686-9.
6
Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines.让孕妇参与新冠疫苗的临床研究。
JAMA. 2021 Mar 16;325(11):1041-1042. doi: 10.1001/jama.2021.1865.
7
Coronavirus disease 2019 vaccines in pregnancy.2019冠状病毒病疫苗在孕期的应用
Am J Obstet Gynecol MFM. 2021 Mar;3(2):100295. doi: 10.1016/j.ajogmf.2020.100295. Epub 2020 Dec 10.
8
Data Centre Profile: The Provincial Health Data Centre of the Western Cape Province, South Africa.数据中心简介:南非西开普省省级卫生数据中心
Int J Popul Data Sci. 2019 Nov 20;4(2):1143. doi: 10.23889/ijpds.v4i2.1143.
9
Understanding and Responding to Prescribing Patterns of Sodium Valproate-Containing Medicines in Pregnant Women and Women of Childbearing Age in Western Cape, South Africa.理解和应对南非西开普省孕妇和育龄妇女中含有丙戊酸钠药物的处方模式。
Drug Saf. 2021 Jan;44(1):41-51. doi: 10.1007/s40264-020-00987-4.
10
Safety and Effectiveness of Isoniazid Preventive Therapy in Pregnant Women Living with Human Immunodeficiency Virus on Antiretroviral Therapy: An Observational Study Using Linked Population Data.抗逆转录病毒治疗中妊娠人类免疫缺陷病毒感染者异烟肼预防治疗的安全性和有效性:利用人群数据关联的观察性研究。
Clin Infect Dis. 2020 Nov 5;71(8):e351-e358. doi: 10.1093/cid/ciz1224.